Literature DB >> 11275004

2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor.

S Kagota1, Y Yamaguchi, K Nakamura, T Sugiura, K Waku, M Kunitomo.   

Abstract

We investigated whether 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, is involved in acetylcholine- and calcium ionophore A23187-induced relaxations in the presence of N(G)-nitro-L-arginine methyl ester (L-NAME) and indomethacin, which is considered to be mediated by endothelium-derived hyperpolarizing factor (EDHF). In rabbit mesenteric arterial rings pre-constricted with noradrenaline, 2-arachidonoylglycerol caused concentration-dependent relaxation. The 2-arachidonoylglycerol-induced relaxations were not affected by endothelium removal. N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-caroxamide (SR141716A) and 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morholinyl-1H-pyrazole-3-carboxamide (AM281), cannabinoid CB(1) receptor antagonists, significantly attenuated 2-arachidonoylglycerol-induced relaxation and the acetylcholine-induced relaxation only slightly, but not the calcium ionophore A23187-induced relaxation. On the other hand, charybdotoxin plus apamin, K(+) channel blockers, significantly attenuated acetylcholine and calcium ionohore A23187-induced relaxations but not 2-arachidonoylglycerol-induced relaxations. These results suggest that 2-arachidonoylglycerol can cause relaxations via cannabinoid CB(1) receptors, but is not involved in EDHF-mediated relaxations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275004     DOI: 10.1016/s0014-2999(01)00833-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  The complexities of the cardiovascular actions of cannabinoids.

Authors:  Michael D Randall; David A Kendall; Saoirse O'Sullivan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.

Authors:  Pui Man Hoi; C Robin Hiley
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol.

Authors:  W S V Ho; X Zheng; D X Zhang
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

4.  Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.

Authors:  W-S Vanessa Ho; C Robin Hiley
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

5.  Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis.

Authors:  Victor M Pulgar; Liliya M Yamaleyeva; Jasmina Varagic; Carolynne M McGee; Michael Bader; Ralf Dechend; Allyn C Howlett; K Bridget Brosnihan
Journal:  Hypertension       Date:  2014-06-16       Impact factor: 10.190

Review 6.  Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).

Authors:  Hester van Diepen; Eberhard Schlicker; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-25       Impact factor: 3.000

7.  Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.

Authors:  W-S V Ho; M D Randall
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

8.  Serum contents of endocannabinoids are correlated with blood pressure in depressed women.

Authors:  W S Vanessa Ho; Matthew N Hill; Gregory E Miller; Boris B Gorzalka; Cecilia J Hillard
Journal:  Lipids Health Dis       Date:  2012-02-28       Impact factor: 3.876

Review 9.  Vascular targets for cannabinoids: animal and human studies.

Authors:  Christopher Stanley; Saoirse E O'Sullivan
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

10.  Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries.

Authors:  Christopher P Stanley; Saoirse E O'Sullivan
Journal:  Pharmacol Res       Date:  2014-02-16       Impact factor: 7.658

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.